Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity
- PMID: 27163633
- PMCID: PMC4943463
- DOI: 10.1021/acs.biochem.6b00382
Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity
Abstract
Human APOBEC3B (A3B) is a member of the APOBEC3 (A3) family of cytidine deaminases, which function as DNA mutators and restrict viral pathogens and endogenous retrotransposons. Recently, A3B was identified as a major source of genetic heterogeneity in several human cancers. Here, we determined the solution nuclear magnetic resonance structure of the catalytically active C-terminal domain (CTD) of A3B and performed detailed analyses of its deaminase activity. The core of the structure comprises a central five-stranded β-sheet with six surrounding helices, common to all A3 proteins. The structural fold is most similar to that of A3A and A3G-CTD, with the most prominent difference being found in loop 1. The catalytic activity of A3B-CTD is ∼15-fold lower than that of A3A, although both exhibit a similar pH dependence. Interestingly, A3B-CTD with an A3A loop 1 substitution had significantly increased deaminase activity, while a single-residue change (H29R) in A3A loop 1 reduced A3A activity to the level seen with A3B-CTD. This establishes that loop 1 plays an important role in A3-catalyzed deamination by precisely positioning the deamination-targeted C into the active site. Overall, our data provide important insights into the determinants of the activities of individual A3 proteins and facilitate understanding of their biological function.
Conflict of interest statement
The authors declare no competing financial interest.
Figures
Similar articles
-
Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B.J Chem Theory Comput. 2019 Jan 8;15(1):637-647. doi: 10.1021/acs.jctc.8b00545. Epub 2018 Dec 11. J Chem Theory Comput. 2019. PMID: 30457868 Free PMC article.
-
Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation.Nucleic Acids Res. 2017 Jul 7;45(12):7494-7506. doi: 10.1093/nar/gkx362. Nucleic Acids Res. 2017. PMID: 28575276 Free PMC article.
-
AID, APOBEC3A and APOBEC3B efficiently deaminate deoxycytidines neighboring DNA damage induced by oxidation or alkylation.Biochim Biophys Acta Gen Subj. 2019 Nov;1863(11):129415. doi: 10.1016/j.bbagen.2019.129415. Epub 2019 Aug 9. Biochim Biophys Acta Gen Subj. 2019. PMID: 31404619
-
Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.J Gen Virol. 2016 Jan;97(1):1-17. doi: 10.1099/jgv.0.000320. Epub 2015 Oct 20. J Gen Virol. 2016. PMID: 26489798 Free PMC article. Review.
-
Structural features of antiviral DNA cytidine deaminases.Biol Chem. 2013 Nov;394(11):1357-70. doi: 10.1515/hsz-2013-0165. Biol Chem. 2013. PMID: 23787464 Review.
Cited by
-
Dimerization regulates both deaminase-dependent and deaminase-independent HIV-1 restriction by APOBEC3G.Nat Commun. 2017 Sep 19;8(1):597. doi: 10.1038/s41467-017-00501-y. Nat Commun. 2017. PMID: 28928403 Free PMC article.
-
Evaluation of APOBEC3B Recognition Motifs by NMR Reveals Preferred Substrates.ACS Chem Biol. 2018 Sep 21;13(9):2427-2432. doi: 10.1021/acschembio.8b00639. Epub 2018 Aug 27. ACS Chem Biol. 2018. PMID: 30130388 Free PMC article.
-
Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes.Nat Commun. 2024 Mar 18;15(1):2370. doi: 10.1038/s41467-024-45909-5. Nat Commun. 2024. PMID: 38499542 Free PMC article.
-
Structure-Based Design of First-Generation Small Molecule Inhibitors Targeting the Catalytic Pockets of AID, APOBEC3A, and APOBEC3B.ACS Pharmacol Transl Sci. 2021 Jul 19;4(4):1390-1407. doi: 10.1021/acsptsci.1c00091. eCollection 2021 Aug 13. ACS Pharmacol Transl Sci. 2021. PMID: 34423273 Free PMC article.
-
Mechanism for APOBEC3G catalytic exclusion of RNA and non-substrate DNA.Nucleic Acids Res. 2019 Aug 22;47(14):7676-7689. doi: 10.1093/nar/gkz550. Nucleic Acids Res. 2019. PMID: 31424549 Free PMC article.
References
-
- Harris RS, Petersen-Mahrt SK, Neuberger MS. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol Cell. 2002;10:1247–1253. - PubMed
-
- Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, Watt IN, Neuberger MS, Malim MH. DNA deamination mediates innate immunity to retroviral infection. Cell. 2003;113:803–809. - PubMed
-
- Lecossier D, Bouchonnet F, Clavel F, Hance AJ. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science. 2003;300:1112. - PubMed
-
- Yu Q, König R, Pillai S, Chiles K, Kearney M, Palmer S, Richman D, Coffin JM, Landau NR. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat Struct Mol Biol. 2004;11:435–442. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
